Surmodics, Inc. designs and manufactures medical devices. The Company offers coronary stent systems, angioplasty catheters, chronic total occlusion devices, specialty guide wires, and intravascular sensors.
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential
SurModics news
27.04.2022
SurModics' GAAP loss for 6 months of fiscal year 2022 was $6.895 million, compared to a profit of $7.813 million in the previous year. Revenue decreased 14.3% to $49.109 million from $57.292 million a year earlier.
Source: 
surmodics.gcs-web.com
surmodics.gcs-web.com
03.02.2022
The loss of SurModics under GAAP for 3 months of fiscal year 2022 was $2.812 million, up 10.3 times from $0.274 million in the previous year. Revenue increased 3.2% to $23.003 million from $22.297 million a year earlier.
Source: surmodics.gcs-web.com
surmodics.gcs-web.com
10.11.2021
SurModics' GAAP net income for fiscal year 2021 was $4.237 million, up 3.77 times from $1.123 million in the previous year. Revenue increased 10.8% to $105.136 million from $94.864 million a year earlier.
Source: surmodics.gcs-web.com
surmodics.gcs-web.com
04.08.2021
SurModics' GAAP net income for 9 months of fiscal year 2021 was $4.526 million, up 11.2% from $4.069 million in the prior year. Revenue increased 12.2% to $81.165 million from $72.321 million a year earlier.
Source: surmodics.gcs-web.com
surmodics.gcs-web.com
General information
| Company name | SurModics |
|---|---|
| Tags | #medtech |
| Sector | Health Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Equipment |
| Business address | 9924 W 74TH ST EDEN PRAIRIE MN 55344 9525007000 |
| Mailing address | 9924 WEST 74TH ST EDEN PRAIRIE MN 55344 |
| Website | www.surmodics.com |
| Information disclosure | www.sec.gov |
English (US) 